중추신경계 치료제 시장 규모, 점유율, 성장 분석 : 약제 유형별, 질환 유형별, 투여 경로별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Central Nervous System Treatment Market size was valued at USD 144.96 Billion in 2024 and is poised to grow from USD 154.09 Billion in 2025 to USD 251.22 Billion by 2033, growing at a CAGR of 6.3% during the forecast period (2026-2033).

The increasing prevalence of chronic and central nervous system (CNS) disorders globally underscores the need for effective treatment solutions. A multidisciplinary approach involving specialists such as neurosurgeons, neurologists, and physical therapists is essential for comprehensive care. Ongoing advancements in neuroscience are fueling the development of innovative treatment options, including new surgical techniques, gene therapies, and enhanced neuroimaging technologies. The global market for CNS treatments is anticipated to grow due to rising diagnostic capabilities and the increasing incidence of CNS disorders. The shift towards generic medications, facilitated by patent expirations, particularly benefits low- and middle-income countries, enhancing market competition. Regulatory support and focused clinical trials foster the introduction of novel therapies, while recent R&D efforts have paved the way for advanced drug delivery systems in CNS treatment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Central Nervous System Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Central Nervous System Treatment Market Segments Analysis

Global Central Nervous System Treatment Market is segmented by Drug Type, Disease Type, Route of Administration, Distribution Channel and region. Based on Drug Type, the market is segmented into Anesthetics, Anticonvulsants, Antidepressants, Antiemetics, CNS Stimulants, Anti-Parkinson's Drugs, Anti-Alzheimer's Drugs, Pain Relievers and Others. Based on Disease Type, the market is segmented into Neurodegenerative Diseases, Mental Health Disorders, Neurovascular Diseases, Infectious Diseases, Trauma-related CNS Disorders, CNS Cancer and Others. Based on Route of Administration, the market is segmented into Oral, Injectable, Transdermal, Intranasal and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Central Nervous System Treatment Market

The global Central Nervous System Treatment market is being strongly driven by the escalating prevalence of neurological disorders, such as multiple sclerosis, Alzheimer's disease, and Parkinson's disease. This surge in cases is becoming increasingly evident around the world, significantly influencing market expansion. Moreover, nations with growing elderly populations are witnessing a corresponding rise in Alzheimer's disease cases. Currently, millions are affected by this condition, and projections indicate that this number will continue to climb dramatically in the foreseeable future. As these challenges become more pronounced, the demand for effective treatments and interventions is anticipated to escalate, further propelling market growth.

Restraints in the Global Central Nervous System Treatment Market

The Global Central Nervous System Treatment market faces several constraints, largely due to the substantial investments required for therapeutic research and development compared to other areas. The complexity of therapies targeting the central nervous system necessitates a high level of precision, which in turn leads to a shortage of qualified medical professionals equipped to handle these challenges. Additionally, the process of obtaining drug approval for treatments that influence brain function and behavior is notoriously protracted, often spanning several years, thereby hindering timely advancements and accessibility in this crucial field of medicine.

Market Trends of the Global Central Nervous System Treatment Market

The Global Central Nervous System (CNS) Treatment market is experiencing robust growth driven by an increase in neurological disorders, rising aging populations, and advancements in pharmaceutical research. A surge in investments from both public and private sectors is enhancing the development of innovative therapies, including biologics and personalized medicine. Additionally, the integration of digital health technologies and artificial intelligence in treatment protocols is reshaping patient care pathways, resulting in more effective and tailored treatment options. Growing awareness and improved diagnostic capabilities are further propelling demand, positioning the CNS treatment sector as a dynamic and pivotal area within the healthcare landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Technology Analysis
• Case Studies
• Patent Analysis
• Value Chain Analysis
• Trade Analysis
• Pipeline Analysis
• Clinical Trials
• Raw Material Analysis
• Startup Analysis
• Pricing Analysis
• Regulatory Analysis

Global Central Nervous System Treatment Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Anesthetics
• Anticonvulsants
• Antidepressants
• Antiemetics
• CNS Stimulants
• Anti-Parkinson's Drugs
• Anti-Alzheimer's Drugs
• Pain Relievers
• Others

Global Central Nervous System Treatment Market Size by Disease Type & CAGR (2026-2033)

• Market Overview
• Neurodegenerative Diseases
  • Alzheimer's Disease
  • Parkinson's Disease
  • Huntington's Disease
  • Multiple Sclerosis
  • Amyotrophic Lateral Sclerosis (ALS)
  • Others
• Mental Health Disorders
  • Depression
  • Schizophrenia
  • Bipolar Disorder
  • Epilepsy
  • Anxiety Disorders
  • Others
• Neurovascular Diseases
  • Stroke
  • Cerebral Aneurysm
  • Vascular Dementia
  • Others
• Infectious Diseases
  • Meningitis
  • Encephalitis
  • Others
• Trauma-related CNS Disorders
  • Traumatic Brain Injury
  • Spinal Cord Injury
  • Others
• CNS Cancer
• Others

Global Central Nervous System Treatment Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Oral
• Injectable
• Transdermal
• Intranasal
• Others

Global Central Nervous System Treatment Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores
• Others

Global Central Nervous System Treatment Market Size & CAGR (2026-2033)

• North America (Drug Type, Disease Type, Route of Administration, Distribution Channel)
  • US
  • Canada
• Europe (Drug Type, Disease Type, Route of Administration, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Type, Disease Type, Route of Administration, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Type, Disease Type, Route of Administration, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Type, Disease Type, Route of Administration, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squibb
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Pharmaceutical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech/Eisai
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurocrine Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GSK
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• H. Lundbeck
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acorda Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alzheon
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Delix Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerevel Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations